Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Down 0.6% – Should You Sell?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s stock price traded down 0.6% on Wednesday . The company traded as low as $0.8548 and last traded at $0.8548. 101 shares traded hands during trading, a decline of 99% from the average daily volume of 9,053 shares. The stock had previously closed at $0.8603.

Peak Pharmaceuticals Trading Down 0.6%

The company’s 50 day moving average price is $1.01 and its 200-day moving average price is $1.66.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Articles

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.